Research lacking on drugs for older children with autism, study finds

September 24, 2012 by Serena Gordon, Healthday Reporter
Research lacking on drugs for older children with autism, study finds
Majority seem to be 'taking medications we have very little evidence for,' doctor says.

(HealthDay)—More and more children are growing up with autism, and although many treatments and interventions are now available, clinical studies on the use of medications in teens and young adults are lacking, according to new research.

"The majority of (older) individuals with spectrum disorders appear to be taking medications that we have very little evidence for," said the study's lead author, Dr. Jeremy Veenstra-VanderWeele, director of the Treatment and Research Institute for Autism Spectrum Disorders at the Vanderbilt Brain Institute in Nashville, Tenn.

"In the absence of sufficient evidence, parents and people with autism should find a clinician who tells you what's known and unknown about the potential benefits and risks of any medication," he said. "It should be a shared decision-making process."

Results of the study were published online on Sept. 24 in the journal Pediatrics.

Autism spectrum disorders are that impair social development and communication. Autism spectrum disorders also may cause and even self-abusive behavior, such as head banging, according to the U.S. National Institute of Neurological Disorders and Stroke (NINDS).

It is estimated that about one in 88 American children has been identified with an autism spectrum disorder

As children with autism age, some do experience significant improvements, according to NINDS, but many do not. There is no cure for autism, although there are many treatments available, including education and and medications.

Medications usually are used to treat some of the symptoms associated with autism, rather than the core symptoms of the condition, according to background information in the new study. For example, the medication risperidone (brand name Risperdal) may be used to treat behavioral symptoms associated with autism, such as aggression, outbursts and irritability, said Dr. Melissa Nishawala, medical director of the Clinical and Research Program at the NYU Child Study Center in New York City.

"Medications like risperidone and aripiprazole don't address the cause of autism, but they help calm down [people with autism]," Veenstra-VanderWeele said.

For the new study, the researchers reviewed medical literature from 1980 through 2011 to find clinical trials on drugs for people with autism between the ages of 13 and 30 years old. They found eight studies with at least 20 participants. Two investigators independently assessed the quality of the studies.

The researchers said they found four studies of fair quality while the other four were poor. The studies included reviews of antipsychotic medications, such as risperidone and haloperidol (Haldol); serotonin reuptake inhibitors, such as fluvoxamine (Luvox) and clomipramine (Anafranil); and opioid receptor agonists, such as naltrexone (Depade).

The researchers felt that, overall, there wasn't enough data on medications in the teen and young adult autism population. Risperidone wasn't well studied in teens and young adults, but there was evidence for its use if the entire pediatric population was considered, the study said.

Although behavioral and educational interventions weren't included in the new study, Veenstra-VanderWeele said he suspects there's a lack of evidence for these types of treatments in older children and young adults too.

"We really don't know if intensive behavior interventions continue to benefit individuals as they get older," he said.

NYU's Nishawala said: "The most important thing for parents to take away is that we know there are a few medications that have been studied that can help. Certain symptoms like irritability, agitation and aggression can be controlled with medications, but there's lesser evidence that repetitive behaviors can be treated."

Nishawala added that although she and others who treat older children and with autism would love to have more evidence-based research on the medications they use, it can be difficult to get parents and to participate in clinical trials when medications are already available to them for what's known as "off-label" use. That's when doctors prescribe medications for a condition for which the drug has yet to receive U.S. Food and Drug Administration approval.

In addition, she said, it's difficult to get funding for trials, particularly when a drug already has been approved.

Explore further: Little evidence supports autism treatment options in adolescents

More information: Learn more about autism and teens from the Nemours Foundation.

Related Stories

Little evidence supports autism treatment options in adolescents

August 27, 2012
Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.

Repetitive behaviors in adults with Autism Spectrum disorders significantly lessen with antidepressant treatment

December 5, 2011
(Medical Xpress) -- Restricted, repetitive behavior, such as compulsive arranging and rigid adherence to routines, is a defining symptom of autism spectrum disorders.

New clinical trial to examine medication to treat social withdrawal in Fragile X and autism

July 20, 2011
Children and adults with social withdrawal due to Fragile X syndrome, the most common cause of inherited intellectual disability and the most common known single gene cause of autism, may benefit from an experimental drug ...

Recommended for you

Video game improves balance in youth with autism

November 21, 2017
Playing a video game that rewards participants for holding various "ninja" poses could help children and youth with autism spectrum disorder (ASD) improve their balance, according to a recent study in the Journal of Autism ...

Potential new autism drug shows promise in mice

November 14, 2017
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, called NitroSynapsin, largely corrected electrical, behavioral and brain abnormalities in the ...

Relational factors in music therapy can contribute to positive outcome for children with autism

November 6, 2017
It might not surprise that good relationships create good outcomes, as meaningful relational experiences are crucial to all of us in our everyday life. However, the development of a relationship with a child with autism may ...

In autism, too many brain connections may be at root of condition

November 2, 2017
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form ...

New autism study a "shocking wake-up call" for society, say academics

October 23, 2017
People who show characteristics of autism are more at risk of attempting suicide, according to a Coventry University study whose results are being presented to a United States federal advisory committee tomorrow.

Signaling pathway may be key to why autism is more common in boys

October 17, 2017
Researchers aiming to understand why autism spectrum disorders (ASD) are more common in boys have discovered differences in a brain signaling pathway involved in reward learning and motivation that make male mice more vulnerable ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.